Linsen Ye

2.5k total citations
37 papers, 728 citations indexed

About

Linsen Ye is a scholar working on Oncology, Cancer Research and Immunology. According to data from OpenAlex, Linsen Ye has authored 37 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Cancer Research and 12 papers in Immunology. Recurrent topics in Linsen Ye's work include Cancer Immunotherapy and Biomarkers (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and MicroRNA in disease regulation (5 papers). Linsen Ye is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and MicroRNA in disease regulation (5 papers). Linsen Ye collaborates with scholars based in China, Nigeria and United States. Linsen Ye's co-authors include Guihua Chen, Qi Zhang, Yinan Deng, Guoying Wang, Xiaolong Chen, Yingjiao Cao, Mengchen Shi, Yusheng Cheng, Liting Zhang and Tong Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Linsen Ye

33 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linsen Ye China 13 293 266 207 197 106 37 728
Xiaolei Shi China 11 502 1.7× 103 0.4× 100 0.5× 317 1.6× 135 1.3× 14 802
Piera Filomena Fiore Italy 16 258 0.9× 172 0.6× 99 0.5× 85 0.4× 87 0.8× 25 660
Yohei Yamamoto Japan 13 176 0.6× 160 0.6× 87 0.4× 83 0.4× 37 0.3× 25 604
Yoka H. Kusumanto Netherlands 8 315 1.1× 95 0.4× 450 2.2× 226 1.1× 61 0.6× 14 957
Zhiyong Du China 15 318 1.1× 49 0.2× 217 1.0× 188 1.0× 100 0.9× 38 676
Minsuk Kwon South Korea 16 336 1.1× 276 1.0× 486 2.3× 157 0.8× 19 0.2× 47 984
Alexandru‐Emil Matei Germany 12 271 0.9× 106 0.4× 130 0.6× 52 0.3× 38 0.4× 27 730
John R. Wilson‐Kanamori United Kingdom 5 245 0.8× 152 0.6× 97 0.5× 51 0.3× 98 0.9× 7 703
Sara K. Daniel United States 10 166 0.6× 236 0.9× 376 1.8× 141 0.7× 48 0.5× 21 728
Andrew J. Robson United Kingdom 7 211 0.7× 170 0.6× 141 0.7× 123 0.6× 317 3.0× 8 799

Countries citing papers authored by Linsen Ye

Since Specialization
Citations

This map shows the geographic impact of Linsen Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linsen Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linsen Ye more than expected).

Fields of papers citing papers by Linsen Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linsen Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linsen Ye. The network helps show where Linsen Ye may publish in the future.

Co-authorship network of co-authors of Linsen Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Linsen Ye. A scholar is included among the top collaborators of Linsen Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linsen Ye. Linsen Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Bo, Haibo Li, Zhan‐Cheng Zeng, et al.. (2025). METTL3 knockout accelerates hepatocarcinogenesis via inhibiting endoplasmic reticulum stress response. FEBS Open Bio. 15(7). 1144–1158.
2.
Hu, Yongwei, Wang Li, Lei Lyu, et al.. (2025). Multi-faceted nanodrug reinforcing metalloimmunotherapy for hepatocellular carcinoma. Biomaterials. 329. 123899–123899.
3.
Li, Xiaojing, Kun Li, Yongwei Hu, et al.. (2025). Tissue-resident peripheral helper T cells foster hepatocellular carcinoma immune evasion by promoting regulatory B-cell expansion. Chinese Medical Journal. 138(17). 2148–2158. 1 indexed citations
4.
Wang, Xiangyang, Linsen Ye, Yuhao Zheng, et al.. (2025). FXR inhibition functions as a checkpoint blockade of the pathogenic Tfh cell response in lupus. Cellular and Molecular Immunology. 22(8). 889–900. 1 indexed citations
5.
Chen, Gang, et al.. (2025). Research landscape and trends of human umbilical cord mesenchymal stem cell-derived exosomes. Stem Cell Research & Therapy. 16(1). 259–259. 1 indexed citations
6.
Ye, Linsen, et al.. (2023). Properties and microstructure of C f /HfC‐SiC composite prepared by combined process. International Journal of Applied Ceramic Technology. 21(1). 230–239. 4 indexed citations
7.
8.
He, Lin, et al.. (2023). Ultrafine-grained W-based alloys prepared by HIP with ultrahigh hardness and excellent thermal stability. International Journal of Refractory Metals and Hard Materials. 115. 106318–106318. 2 indexed citations
9.
Liu, Rongqiang, Shi‐Nan Wu, Hao Yu, et al.. (2023). Prediction model for hepatocellular carcinoma recurrence after hepatectomy: Machine learning-based development and interpretation study. Heliyon. 9(11). e22458–e22458. 7 indexed citations
10.
Li, Siqi, Yang Yang, & Linsen Ye. (2022). Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy. World Journal of Gastroenterology. 28(42). 6034–6044. 16 indexed citations
11.
Yang, Qing, Yingcai Zhang, Linsen Ye, et al.. (2021). Camrelizumab (SHR-1210) treatment for recurrent hepatocellular carcinoma after liver transplant: A report of two cases. Liver Research. 6(2). 111–115. 2 indexed citations
12.
Yuan, Zenan, Linsen Ye, Xiao Feng, et al.. (2021). YAP‐Dependent Induction of CD47‐Enriched Extracellular Vesicles Inhibits Dendritic Cell Activation and Ameliorates Hepatic Ischemia‐Reperfusion Injury. Oxidative Medicine and Cellular Longevity. 2021(1). 6617345–6617345. 12 indexed citations
13.
Li, Kun, et al.. (2021). Novel organoid model in drug screening: Past, present, and future. Liver Research. 5(2). 72–78. 12 indexed citations
14.
Liu, Rongqiang, et al.. (2021). NTF3 Correlates With Prognosis and Immune Infiltration in Hepatocellular Carcinoma. Frontiers in Medicine. 8. 795849–795849. 14 indexed citations
15.
Li, Jing, Linsen Ye, Lele Zhang, et al.. (2021). Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma. Pharmacogenomics and Personalized Medicine. Volume 14. 927–945. 12 indexed citations
16.
17.
Ye, Linsen, Kun Li, Rongqiang Liu, et al.. (2021). Regulation Network and Prognostic Significance of Aldo-Keto Reductase (AKR) Superfamily Genes in Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. Volume 8. 997–1021. 14 indexed citations
18.
Gong, Yihang, Kun Li, Yunfei Qin, et al.. (2021). Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 711448–711448. 22 indexed citations
19.
Ye, Linsen, Qi Zhang, Yusheng Cheng, et al.. (2018). Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion. Journal for ImmunoTherapy of Cancer. 6(1). 145–145. 242 indexed citations
20.
Cheng, Yusheng, Xiaolong Chen, Linsen Ye, et al.. (2018). The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study. Cellular Physiology and Biochemistry. 51(6). 2746–2759. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaolei Shi Breakdown of academic impact, for papers by Piera Filomena Fiore Breakdown of academic impact, for papers by Yohei Yamamoto Breakdown of academic impact, for papers by Yoka H. Kusumanto Breakdown of academic impact, for papers by Zhiyong Du Breakdown of academic impact, for papers by Minsuk Kwon Breakdown of academic impact, for papers by Alexandru‐Emil Matei Breakdown of academic impact, for papers by John R. Wilson‐Kanamori Breakdown of academic impact, for papers by Sara K. Daniel Breakdown of academic impact, for papers by Andrew J. Robson
Rankless by CCL
2026